Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00580528
Other study ID # 0352-05-FB
Secondary ID 5R01NR004861-063
Status Completed
Phase N/A
First received
Last updated
Start date August 1, 2006
Est. completion date May 1, 2011

Study information

Verified date August 2023
Source University of Nebraska
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effectiveness of a theory-based intervention tailored to constructs in the Health Promotion Model and delivered by two distance modes to achieve improvement in healthy eating and physical activity for the control of blood pressure (BP) among an underserved and vulnerable population of prehypertensive rural women aged 50 to 69.


Description:

Hypertension (HTN), a major health problem in the US, is the most prevalent modifiable risk factor for cardio-vascular disease (CVD), the leading killer of women. The incidence of HTN in women increases markedly after menopause, equaling or exceeding that in men. The prehypertension category of blood pressure (BP) -- systolic BP of 120-139 mm Hg or diastolic BP of 80-89 mm Hg -- designates individuals at high risk of developing HTN. Prehypertensive women are not candidates for drug therapy, but for lifestyle modifications to prevent progression to HTN and CVD. Recommended lifestyle modifications include adoption of the Dietary Approaches to Stop Hypertension (DASH) diet that is high in fruits, vegetables and low fat dairy products; dietary sodium reduction; regular endurance physical activity supplemented by resistance exercise; and weight reduction by those who are overweight or obese. A few studies of face-to-face individual and/or group interventions have demonstrated that these lifestyle modifications could lower BP over 6 months in pre-hypertensive individuals. There remains a need to develop distance delivery methods to target rural women with similar behavioral interventions to lower BP. This competitive renewal application will build upon our current work in which we demonstrated that computer-generated print (mailed) newsletters tailored to constructs in the Health Promotion Model (HPM) resulted in significant and clinically important changes in behavioral and biomarkers of healthy eating and physical activity in a general population of rural midlife/older women. The proposed randomized controlled trial will evaluate Internet versus mailed print delivery methods for delivering theory-based tailored newsletters to encourage lifestyle change for BP reduction. A sample of 275 prehypertensive rural women aged 50-69 will be randomly assigned 2:2:1 to receive a) tailored messages delivered via the Internet and brief telephone counseling, b) tailored print newsletters delivered via mail and brief telephone counseling, or c) initial standard advice only. Results of this study may lead to expanded access to lifestyle guidance via the Internet by other populations.


Recruitment information / eligibility

Status Completed
Enrollment 289
Est. completion date May 1, 2011
Est. primary completion date May 1, 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 69 Years
Eligibility Inclusion Criteria: - women aged 50-69 - BP in prehypertensive range (SBP 120-139 or DBP 80-89 mm Hg) - speak and read English (including ESL) - able to communicate over the telephone - able to use a computer with minimal assistance - have access to the Internet - have access to a VCR or DVD player - able to walk without an assistive device - answer 'no' to all questions on the Physical Activity Readiness Questionnaire (PAR-Q) or obtain clearance from their physician Exclusion Criteria: - in the maintenance stage of readiness for change in both components of physical activity and all three components of healthy eating behaviors - more than 14 alcoholic drinks per week - taking anti-hypertensive medication, including diuretics - taking cortisone - currently enrolled in a formal program of cardiac rehabilitation or undergoing physical rehabilitation - unable to walk one mile continuously without stopping to rest - current cancer treatment - other physical or medical restrictions that would preclude following the JNC7 recommendations for moderate physical activity and healthy eating.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Tailored Internet Newsletters
Tailored newsletters delivered via the Internet with content for improving eating and activity to reduce blood pressure
Tailored print newsletters delivered via mail
Tailored Newsletters with content to improve eating and activity to reduce blood pressure

Locations

Country Name City State
United States University of Nebraska Medical Center Omaha Nebraska

Sponsors (2)

Lead Sponsor Collaborator
University of Nebraska National Institute of Nursing Research (NINR)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood pressure Blood pressure with the criterion of normotensive status 24 months
Secondary Daily moderate physical activity and strength enhancing/maintenance activities Engaging regularly, preferably daily, in sustained or intermittent (10 minute bouts) moderate physical activity for at least 30 minutes per day and performing physical activities that enhance and maintain muscular strength at least twice a week. 24 months
Secondary DASH diet goals Meeting the DASH diet's average daily goals of no more than 27% of calories from fat, less than 7% of calories from saturated fat 4-5 servings of fruits, 4-5 servings of vegetables, 2-3 servings of low fat dairy products and no more than 2400 mg. sodium. 24 months
See also
  Status Clinical Trial Phase
Completed NCT03313284 - Respiratory Muscle Training and Intermittent Hypoxia: Additive Health Effects? N/A
Completed NCT01741779 - Diet and Whole-body Vibration Training on Cardiovascular and Autonomic Function N/A
Withdrawn NCT01074918 - Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients Phase 1/Phase 2
Completed NCT00288158 - Primary Prevention of Hypertension in Obese Adolescents Phase 2
Completed NCT01190319 - Study: Effects of Strawberries on Blood Pressure N/A
Completed NCT01008176 - Restoring Sleep Homeostasis to Lower Blood Pressure N/A
Unknown status NCT02197910 - Different Dosages of Bioactive Wheat Peptides and Blood Pressure Level and CVD Risk Biomarkers in Healthy Subjects N/A
Recruiting NCT04543656 - Personalized Blood Pressure Care Using IoMTs and Artificial Intelligence N/A
Completed NCT03168789 - Tension Tamer Randomized Control Trial N/A
Completed NCT00553969 - Efficacy of Coreg CR and Lisinopril on Markers for Cardiovascular Functional and Structural Disease Phase 1/Phase 2
Completed NCT00170937 - A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome Phase 4
Completed NCT01741766 - The Effects of Stretching Training on Arterial Function and Autonomic Control N/A
Completed NCT02143817 - Whole Body Vibration Combined With L-citrulline Supplementation on Cardiovascular Function and Body Composition N/A
Terminated NCT00388388 - Losartan Versus Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects Phase 2
Completed NCT02148458 - Short Term Intermittent Fasting and Mediterranean Diet N/A
Terminated NCT01349114 - Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects Phase 4
Completed NCT02038179 - Center of Research Translation (CORT) Project 2 Phase 2/Phase 3
Completed NCT00970931 - Hypertension Prevention in Pre-Hypertensive Individuals Phase 3
Completed NCT01202175 - Effects of the Beta-blocker Nebivolol (Bystolic) on Subjects With High Normal Blood Pressure and/or a Family History of Hypertension Phase 4
Not yet recruiting NCT01364675 - Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects N/A